Monetary Solutions’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$784 Hold
65
– – ﹤0.01% 342
2026
Q2
$1.1K Hold
65
– – ﹤0.01% 312
2026
Q1
$833 Hold
65
– – ﹤0.01% 298
2025
Q4
$584 Buy
+65
New +$895 ﹤0.01% 300

Other funds holding NTLA

Monetary Solutions's NTLA Position: Q3 2026 in Review

Monetary Solutions held its Intellia Therapeutics (NTLA) position steady in Q3 2026 at 65 shares worth $784. The position accounts for ﹤0.01% of the portfolio, ranked #342.

Monetary Solutions first reported a position in NTLA in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.1K in Q2 2026. 308 funds tracked by Wall St. Rank hold NTLA as of Q3 2026.

  • Monetary Solutions held 65 shares of Intellia Therapeutics worth $784 as of Q3 2026.
  • Monetary Solutions left its Intellia Therapeutics share count unchanged in Q3 2026.
  • Intellia Therapeutics made up ﹤0.01% of Monetary Solutions's portfolio in Q3 2026, its #342 holding.
  • Monetary Solutions first reported a position in Intellia Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Monetary Solutions's Intellia Therapeutics position peaked at $1.1K in Q2 2026.
  • 308 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2026.

Based on Monetary Solutions's 13F filing for Q3 2026, filed 22 Oct 2026.